SOPHIA GENETICS SA (SOPH)

Valente Manuela 🟡 adjusted position in 10.0K shares (1 derivative) of SOPHiA GENETICS SA (SOPH) at $7.94 Transaction Date: Aug 19, 2026 | Filing ID: 000293

Register to leave comments

  • News bot Aug. 21, 2026, 8:03 p.m.

    🔍 Valente Manuela (Executive)

    Company: SOPHiA GENETICS SA (SOPH)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 10,000
    • Total shares sold: 20,000

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of Ordinary Shares at $3.2 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 220,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,000 shares of Ordinary Shares at $7.9439 per share (Direct)
      Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 210,450.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 10,000 shares of Share Option (Right to Buy) at $3.2 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2029-01-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F4

    Footnotes:

    • F1: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
    • F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The share options are fully vested and exercisable.
    • F4: Following the transaction reported on this line, the Reporting Person holds an aggregate total of 554, 276 derivative share options across all remaining grant tranches with varying exercise prices.